About Koneksa

News + Announcements

Koneksa Press Release KH007 Topline Results thumbnail image
News

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

Study meets primary compliance endpoint, reinforcing the value of Koneksa’s integrated measurement platform and syndicated, precompetitive study model with partners Merck and Regeneron. Punta Gorda, FL  — September 1, 2026 —Koneksa Health…
News

Koneksa Launches the First Intelligent Submission Software to Unify the Clinical Submission Pipeline in a Single Auditable Workflow

Purpose-built for biometrics and regulatory operations, Lodestar™ eliminates submission pipeline fragmentation through AI-assisted, auditable workflow, validated in completed LEARNS clinical study.   New York, NY — June 2, 2026 —…
database lock
News

Koneksa Achieves Key Milestone with Database Lock for KH007 Study Evaluating Parkinson’s Disease Progression

Completion of data collection enables full analysis, with topline results expected in June 2026   New York, NY — 23 April 2026 — Koneksa, a measurement-science partner for clinical development,…
NewsKoneksa Recognized in Multiple Independent Digital Biomarkers Market Reports Amid Accelerating Industry Growth
March 17, 2026

Koneksa Recognized in Multiple Independent Digital Biomarkers Market Reports Amid Accelerating Industry Growth

Inclusion across leading analyses reflects growing adoption of digital biomarkers and growing need for more rigorous measurement strategies in clinical development    New York, NY  — March 17, 2026 —…
Koneksa Health
NewsCelebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)
January 13, 2025

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD)  achieved the last patient in (LPI) on January 10, 2025. This is…
Koneksa Health
2024_Dec10_News_thumbnailNewsKoneksa Publishes Syndication Model to Accelerate Drug Discovery Using Digital Health Data in Clinical and Translational Science
December 10, 2024

Koneksa Publishes Syndication Model to Accelerate Drug Discovery Using Digital Health Data in Clinical and Translational Science

New York, NY – December 10, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today a publication in Clinical and Translational Science, titled: “Syndication in Science:…
Koneksa Health
NewsKoneksa Appoints Eric Luthi as Chief Business Officer
November 11, 2024

Koneksa Appoints Eric Luthi as Chief Business Officer

NEW YORK–(BUSINESS WIRE)– Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the appointment of Eric Luthi as Chief Business Officer. In this newly created role, Mr. Luthibrings…
Koneksa Health
NewsKoneksa Announces Regeneron Joins Data Syndication Program for Parkinson’s Digital Biomarkers Study
September 3, 2024

Koneksa Announces Regeneron Joins Data Syndication Program for Parkinson’s Digital Biomarkers Study

NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today that Regeneron has become a member of its Data Syndication Program for the LEARNS observational study. This…
Koneksa Health
NewsKoneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer
April 25, 2024

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

New York, NY – April 25, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today first patient enrolled in a pilot study collecting patient-generated health data…
Koneksa Health
Koneksa Press Release KH007 Topline Results thumbnail imageNewsKoneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression
September 1, 2026

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

Study meets primary compliance endpoint, reinforcing the value of Koneksa’s integrated measurement platform and syndicated, precompetitive study model with partners Merck and Regeneron. Punta Gorda, FL  — September 1, 2026 —Koneksa Health…
Koneksa Health
NewsKoneksa Launches the First Intelligent Submission Software to Unify the Clinical Submission Pipeline in a Single Auditable Workflow
June 2, 2026

Koneksa Launches the First Intelligent Submission Software to Unify the Clinical Submission Pipeline in a Single Auditable Workflow

Purpose-built for biometrics and regulatory operations, Lodestar™ eliminates submission pipeline fragmentation through AI-assisted, auditable workflow, validated in completed LEARNS clinical study.   New York, NY — June 2, 2026 —…
Koneksa Health
database lockNewsKoneksa Achieves Key Milestone with Database Lock for KH007 Study Evaluating Parkinson’s Disease Progression
April 23, 2026

Koneksa Achieves Key Milestone with Database Lock for KH007 Study Evaluating Parkinson’s Disease Progression

Completion of data collection enables full analysis, with topline results expected in June 2026   New York, NY — 23 April 2026 — Koneksa, a measurement-science partner for clinical development,…
Koneksa Health
NewsKoneksa Recognized in Multiple Independent Digital Biomarkers Market Reports Amid Accelerating Industry Growth
March 17, 2026

Koneksa Recognized in Multiple Independent Digital Biomarkers Market Reports Amid Accelerating Industry Growth

Inclusion across leading analyses reflects growing adoption of digital biomarkers and growing need for more rigorous measurement strategies in clinical development    New York, NY  — March 17, 2026 —…
Koneksa Health
NewsCelebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)
January 13, 2025

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD)  achieved the last patient in (LPI) on January 10, 2025. This is…
Koneksa Health
2024_Dec10_News_thumbnailNewsKoneksa Publishes Syndication Model to Accelerate Drug Discovery Using Digital Health Data in Clinical and Translational Science
December 10, 2024

Koneksa Publishes Syndication Model to Accelerate Drug Discovery Using Digital Health Data in Clinical and Translational Science

New York, NY – December 10, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today a publication in Clinical and Translational Science, titled: “Syndication in Science:…
Koneksa Health
NewsKoneksa Appoints Eric Luthi as Chief Business Officer
November 11, 2024

Koneksa Appoints Eric Luthi as Chief Business Officer

NEW YORK–(BUSINESS WIRE)– Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the appointment of Eric Luthi as Chief Business Officer. In this newly created role, Mr. Luthibrings…
Koneksa Health
NewsKoneksa Announces Regeneron Joins Data Syndication Program for Parkinson’s Digital Biomarkers Study
September 3, 2024

Koneksa Announces Regeneron Joins Data Syndication Program for Parkinson’s Digital Biomarkers Study

NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today that Regeneron has become a member of its Data Syndication Program for the LEARNS observational study. This…
Koneksa Health
NewsKoneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer
April 25, 2024

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

New York, NY – April 25, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today first patient enrolled in a pilot study collecting patient-generated health data…
Koneksa Health
NewsKoneksa Announces Merck Joins Data Syndication Partnership Program Around Parkinson’s Digital Biomarkers Observational Study
March 20, 2024

Koneksa Announces Merck Joins Data Syndication Partnership Program Around Parkinson’s Digital Biomarkers Observational Study

New York, NY – March 20, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced that Merck, known as MSD outside of the United States and Canada,…
Koneksa Health
NewsKoneksa Appoints Dr. Jessie Bakker as Vice President of Clinical Development
March 1, 2024

Koneksa Appoints Dr. Jessie Bakker as Vice President of Clinical Development

New York, NY – March 4, 2024 – Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Jessie Bakker, M.S., Ph.D., as Vice President (VP) of Clinical Development.…
Koneksa Health
NewsKoneksa Enrolls First Patient in LEARNS Observational Study to Remotely Measure Disease Progression Using Digital Biomarkers in Neurodegenerative Disorders
February 20, 2024

Koneksa Enrolls First Patient in LEARNS Observational Study to Remotely Measure Disease Progression Using Digital Biomarkers in Neurodegenerative Disorders

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today that the first patient was enrolled in the LEARNS study, an observational study to determine the measurement…
Koneksa Health
NewsKoneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies
January 4, 2024

Koneksa Announces New Multi-Domain Model for Functional Status Assessment Enabled by Digital Health Technologies

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the publication of a new multi-domain model for capturing functional status in oncology through connected digital tools…
Koneksa Health
NewsKoneksa Launches Academic Collaboration Program for Parkinson’s Disease
August 14, 2023

Koneksa Launches Academic Collaboration Program for Parkinson’s Disease

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease (KAPP-PD) to incorporate its Neuroscience…
Koneksa Health
NewsKoneksa Appoints Dave Hurry as Chief Data Officer and Dr. Larsson Omberg as EVP of Data Science
June 27, 2023

Koneksa Appoints Dave Hurry as Chief Data Officer and Dr. Larsson Omberg as EVP of Data Science

NEW YORK–(BUSINESS WIRE)–Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Dave Hurry as Chief Data Officer and Larsson Omberg, Ph.D., as Executive Vice President of Data Science.…
Koneksa Health
NewsKoneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers
June 13, 2023

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

NEW YORK– (BUSINESS WIRE) – Koneksa, the evidence-based digital biomarkers company, announced today a partnership with Beacon Biosignals, the leading computational neurodiagnostics company, to launch a clinical trial to investigate…
Koneksa Health
NewsKoneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials
March 2, 2023

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

NEW YORK– (BUSINESS WIRE) — Koneksa, the evidence-based digital biomarkers company, announced today an extended partnership with SSI Strategy, a life sciences consulting firm, that will provide both organizations with…
Koneksa Health
NewsKoneksa Launches Clinical Trial Evaluating At-Home Mobile Spirometry Using Digital Measures in Moderate Asthma
January 17, 2023

Koneksa Launches Clinical Trial Evaluating At-Home Mobile Spirometry Using Digital Measures in Moderate Asthma

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of a clinical study comparing the treatment effect between at-home mobile spirometry using digital…
Koneksa Health
NewsKoneksa Announces Clinical Pipeline of Validated Digital Biomarkers to Accelerate Life Sciences Research
October 25, 2022

Koneksa Announces Clinical Pipeline of Validated Digital Biomarkers to Accelerate Life Sciences Research

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of its clinical pipeline featuring biomarkers across neuroscience, oncology, respiratory, and other therapeutic areas.…
Koneksa Health
NewsKoneksa Awarded a Grant from The Michael J. Fox Foundation to Evaluate Disease Progression Using Digital Measures in Parkinson’s Disease
August 8, 2022

Koneksa Awarded a Grant from The Michael J. Fox Foundation to Evaluate Disease Progression Using Digital Measures in Parkinson’s Disease

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering digital biomarkers, today announced The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a second research grant to evaluate Parkinson’s…
Koneksa Health
NewsKoneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease
June 16, 2022

Koneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering digital biomarkers, announced today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)…
Koneksa Health
NewsAural Analytics and Koneksa Announce Partnership to Support Clinical Trials Using Speech Analytics
June 14, 2022

Aural Analytics and Koneksa Announce Partnership to Support Clinical Trials Using Speech Analytics

PHOENIX–(BUSINESS WIRE)–Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced today a partnership with Koneksa, a leader in digital biomarker development, to further strengthen its platform and research capabilities…
Koneksa Health
Funding Round thumbnailNewsKoneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform
February 7, 2022

Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform

NEW YORK–(BUSINESS WIRE)–Koneksa, the leader in designing and validating digital biomarkers to accelerate drug development, announced today the completion of a $45M Series C financing round, led by AyurMaya, an…
Koneksa Health
NewsKoneksa Broadens Multi-Year CNS Research Collaboration with Sanofi Digital Clinical Trial Collaboration Expands to Multiple Sclerosis
November 3, 2021

Koneksa Broadens Multi-Year CNS Research Collaboration with Sanofi Digital Clinical Trial Collaboration Expands to Multiple Sclerosis

NEW YORK – November 3, 2021 – Koneksa, the leader in developing and implementing patient-centric digital biomarkers for drug development, today announced that Sanofi, one of the world’s top biopharmaceutical…
Koneksa Health
Funding Round thumbnailNewsKoneksa Completes $16M Series B Financing to Expand Digital Biomarker Platform
September 28, 2020

Koneksa Completes $16M Series B Financing to Expand Digital Biomarker Platform

Koneksa will invest in the continued development of its digital platform for integrating wearables, sensors, and other technologies on a global scale. Financing round was led by Spring Mountain Capital…
Koneksa Health
Study Publication news thumbnailNewsKoneksa Health Announces Study Publication Validating mHealth Technologies in Early-Stage Clinical Trial Safety Monitoring
January 24, 2020

Koneksa Health Announces Study Publication Validating mHealth Technologies in Early-Stage Clinical Trial Safety Monitoring

Wearable Devices Accurately Measure Heart Rate and Blood Pressure to Detect Drug Treatment Effects   NEW YORK, Jan. 24, 2020 /PRNewswire/ — Koneksa Health, the leader in developing and implementing patient-focused digital…
Koneksa Health
New YorkNewsKoneksa Health Announces New U.S. Office
November 6, 2019

Koneksa Health Announces New U.S. Office

NEW YORK, Nov. 6, 2019 /PRNewswire/ — Koneksa Health announced today the opening of its new corporate headquarters in New York. The company, which enables the biopharmaceutical industry to develop new medicines using…
Koneksa Health
NewsKoneksa Announces Publication of Data Assessing Wearable Devices for Vital-Sign Collection
October 1, 2019

Koneksa Announces Publication of Data Assessing Wearable Devices for Vital-Sign Collection

Study suggests wearables offer advantages over traditional methods NEW YORK, Oct. 1, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop new medicines using digital biomarkers and…
Koneksa Health
smartwatch thumbnailNewsKoneksa Health Announces Poster Presentation at ASCO Quality Care Symposium
September 6, 2019

Koneksa Health Announces Poster Presentation at ASCO Quality Care Symposium

Wearable Devices Help Predict Hospitalization Risk for Patients Receiving Chemoradiotherapy   NEW YORK, Sept. 6, 2019 /PRNewswire/ — Koneksa Health today announced a poster presentation of a study expanding initial findings that real-world…
Koneksa Health
London thumbnailNewsKoneksa Health Opens UK Office to Support Growing Business
May 15, 2019

Koneksa Health Opens UK Office to Support Growing Business

Digital health company opens London office headed by Peter Kelly, expert in signal-processing algorithms   NEW YORK and LONDON, May 15, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to…
Koneksa Health
NewsKoneksa Health Announces Addition of Steve Hirschfeld to Board of Directors
April 23, 2019

Koneksa Health Announces Addition of Steve Hirschfeld to Board of Directors

Hirschfeld to Join as Koneksa an Independent Director   NEW YORK, April 23, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop new medicines using innovative solutions…
Koneksa Health
ASCPT 2019 thumbnailNewsKoneksa Health Announces Poster Presentation at the American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting
March 19, 2019

Koneksa Health Announces Poster Presentation at the American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting

Findings validate the use of mHealth technologies in cardiovascular treatment NEW YORK, March 19, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop new…
Koneksa Health
smart watchNewsKoneksa Announces Study Publication Assessing Wearable Digital Devices for Drug Development
February 5, 2019

Koneksa Announces Study Publication Assessing Wearable Digital Devices for Drug Development

Findings demonstrate the importance of analytical and clinical evaluation in the applicability of wearable devices in R&D   NEW YORK, Feb. 5, 2019 /PRNewswire/ — Koneksa Health, a private company that enables…
Koneksa Health
Keystone Symposia conferencesNewsKoneksa CEO Joined Faculty at Keystone Symposium on Digital Health
January 29, 2019

Koneksa CEO Joined Faculty at Keystone Symposium on Digital Health

Chris Benko Presented on Using Wearable Technology in Clinical Trials   NEW YORK, Jan. 29, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop…
Koneksa Health
NewsKoneksa Health Announces Addition to Scientific Advisory Board
January 8, 2019

Koneksa Health Announces Addition to Scientific Advisory Board

Renowned oncologist William A. Wood, MD, MPH, of UNC Lineberger joins scientific advisors   NEW YORK, Jan. 8, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical…
Koneksa Health
ATS American Thoracic SocietyNewsKoneksa Health to Present Asthma Study at the 2018 American Thoracic Society (ATS) International Conference
May 21, 2018

Koneksa Health to Present Asthma Study at the 2018 American Thoracic Society (ATS) International Conference

Validating Remote FEV1 Monitoring in Moderate Asthmatics to Increase Study Power   NEW YORK (PRWEB) MAY 21, 2018 Koneksa Health, an early-stage company focused on the integration of real-world data…
Koneksa Health
continuous data smart watchNewsTracking Physical Activity of Cancer Patients to Avoid Unplanned Hospitalization
December 12, 2016

Tracking Physical Activity of Cancer Patients to Avoid Unplanned Hospitalization

Koneksa Health enables oncology research at Montefiore Einstein Center for Cancer Care by facilitating the collection and visualization of activity data from Garmin vivofit® devices.   NEW YORK, NY (PRWEB)…
Koneksa Health
Takeda logoNewsTakeda and Koneksa Health Announce Strategic Collaboration to Use Digital Health Tools in Clinical Trials
November 7, 2016

Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital Health Tools in Clinical Trials

CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real world data into clinical research,…
Koneksa Health